Rachel E. Solnick

Rachel E. Solnick

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2020 in Academic Emergency Medicine
Verified
Journal Article
Closed access
PDF file
RSRachel E. Solnick
Rachel E. Solnick
GCGrace Chao
Grace Chao
RRRyan Ross
Ryan Ross
GKGordon T. Kraft‐Todd
Gordon T. Kraft‐Todd
KKKeith E. Kocher
Keith E. Kocher

22 January 2021 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
RSRachel E. Solnick
Rachel E. Solnick
HCHwajung Choi
Hwajung Choi
KKKeith E. Kocher
Keith E. Kocher

23 October 2023 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
RSRachel E. Solnick
Rachel E. Solnick
RCRafael Ba Cortes
Rafael Ba Cortes
ECEthan J. Ba Chang
Ethan J. Ba Chang
PDPaul Bs Dudas
Paul Bs Dudas
DDDaxuan Deng
Daxuan Deng
KKKeith E. Kocher
Keith E. Kocher
Background: Emergency departments (EDs) are the primary source of health care for many patients diagnosed with sexually transmitted infections (STIs). Expedited partner therapy (EPT), treating the partner of patients with STIs, is an evidence-based practice for patients who might not otherwise seek care. Little is known about the use of EPT in the ED. In a national survey, we describe ED medical directors' knowledge, attitudes, and practices of EPT. Methods: A cross-sectional survey of medical directors from academic EDs was conducted from July to September 2020 using the Academy of Academic Administrators of Emergency Medicine Benchmarking Group. Primary outcomes were EPT awareness, support, and use. The survey also examined barriers and facilitators. Results: Forty-eight of 70 medical directors (69%) responded. Seventy-three percent were aware of EPT, but fewer knew how to prescribe it (38%), and only 19% of EDs had implemented EPT. Seventy-nine percent supported EPT and were more likely to if they were aware of EPT (89% vs. 54%; P = 0.01). Of nonimplementers, 41% thought EPT was feasible, and 56% thought departmental support would be likely. Emergency department directors were most concerned about legal liability, but a large proportion (44%) viewed preventing sequelae of untreated STIs as “extremely important.” Conclusions: Emergency department medical directors expressed strong support for EPT and reasonable levels of feasibility for implementation but low utilization. Our findings highlight the need to identify mechanisms for EPT implementation in EDs.

17 April 2024 in Emergency Medicine Clinics of North America
Verified
Journal Article
Closed access
RSRachel E. Solnick
Rachel E. Solnick
LLLaura Hernando López
Laura Hernando López
PMPatricia Mae Martinez
Patricia Mae Martinez
JZJason E. Zucker
Jason E. Zucker

13 September 2023 in Western Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
EAEmily E. Ager
Emily E. Ager
WSWilliam Sturdavant
William Sturdavant
ZCZoe Curry
Zoe Curry
FAFahmida Ahmed
Fahmida Ahmed
MDMelissa DeJonckheere
Melissa DeJonckheere
RSRachel E. Solnick
Rachel E. Solnick
Background: Treatment for partners of patients diagnosed with sexually transmitted infections (STI), referred to as expedited partner therapy (EPT), is infrequently used in the emergency department (ED). This was a pilot program to initiate and evaluate EPT through medication-in-hand (“take-home”) kits or paper prescriptions. In this study we aimed to assess the frequency of EPT prescribing, the efficacy of a randomized best practice advisory (BPA) on the uptake, perceptions of emergency clinicians regarding the EPT pilot, and factors associated with EPT prescribing.Methods: We conducted this pilot study at an academic ED in the midwestern US between August–October 2021. The primary outcome of EPT prescription uptake and the BPA impact was measured via chart abstraction and analyzed through summary statistics and the Fisher exact test. We analyzed the secondary outcome of barriers and facilitators to program implementation through ED staff interviews (physicians, physician assistants, and nurses). We used a rapid qualitative assessment method for the analysis of the interviews.Results: During the study period, 52 ED patients were treated for chlamydia/gonorrhea, and EPT was offered to 25% (95% CI 15%–39%) of them. Expedited partner therapy was prescribed significantly more often (42% vs 8%; P < 0.01) when the interruptive pop-up alert BPA was shown compared to not shown. Barriers identified in the interviews included workflow constraints and knowledge of EPT availability. The BPA was viewed positively by the majority of participants.Conclusion: In this pilot EPT program, expedited partner therapy was provided to 25% of ED patients who appeared eligible to receive it. The interruptive pop-up alert BPA significantly increased EPT prescribing. Barriers identified to EPT prescribing should be the subject of future interventions to improve provision of EPT from the emergency department.

22 December 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RSRachel E. Solnick
Rachel E. Solnick
GVGanga Vijayasiri
Ganga Vijayasiri
YLYiting Li
Yiting Li
KKKeith E. Kocher
Keith E. Kocher
GJGrace Jenq
Grace Jenq
DBDavid Bozaan
David Bozaan
Health disparities in heart failure (HF) show that Black patients face greater ED utilization and worse clinical outcomes. Transitional care post-HF hospitalization, such as 7-day early follow-up visits, may prevent ED returns. We examine whether early follow-up is associated with lower ED returns visits within 30 days and whether Black race is associated with receiving early follow-up after HF hospitalization. This was a retrospective cohort analysis of all Black and White adult patients at 13 hospitals in Michigan hospitalized for HF from October 1, 2017, to September 30, 2020. Adjusted risk ratios (aRR) were estimated from multivariable logistic regressions. The analytic sample comprised 6,493 patients (mean age = 71 years (SD 15), 50% female, 37% Black, 9% Medicaid). Ten percent had an ED return within 30 days and almost half (43%) of patients had 7-day early follow-up. Patients with early follow-up had lower risk of ED returns (aRR 0.85 [95%CI, 0.71–0.98]). Regarding rates of early follow-up, there was no overall adjusted association with Black race, but the following variables were related to lower follow-up: Medicaid insurance (aRR 0.90 [95%CI, 0.80–1.00]), dialysis (aRR 0.86 [95%CI, 0.77–0.96]), depression (aRR 0.92 [95%CI, 0.86–0.98]), and discharged with opioids (aRR 0.94 [95%CI, 0.88–1.00]). When considering a hospital-level interaction, three of the 13 sites with the lowest percentage of Black patients had lower rates of early follow-up in Black patients (ranging from 15% to 55% reduced likelihood). Early follow-up visits were associated with a lower likelihood of ED returns for HF patients. Despite this potentially protective association, certain patient factors were associated with being less likely to receive scheduled follow-up visits. Hospitals with lower percentages of Black patients had lower rates of early follow-up for Black patients. Together, these may represent missed opportunities to intervene in high-risk groups to prevent ED returns in patients with HF.